PRTN3 and rheumatoid arthritis: To find biological markers to differentiate this rare type of RA from ACPA-positive, and other subgroups of ACPA-negative RA, whole-exome sequencing and subsequent scRNA-seq were performed to study somatic mutations in CD8+ T cells of an index RA patient.